Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07547280

Comparison of the Effects of External Oblique Intercostal Plane Block and Subcostal Transversus Plane Block Methods With Ultrasound Guidance on Postoperative Analgesia in Laparoscopic Sleeve Gastrectomy Operations

The primary aim of this study was to investigate the effects of the external oblique intercostal plane block and the subcostal transversus abdominis plane block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Obesity is a global health problem currently treated with diet, pharmacotherapy, and bariatric surgery. Laparoscopic sleeve gastrectomy (LSG) is a common bariatric procedure that often results in moderate to severe postoperative pain. Adequate pain control after LSG is crucial for early mobilization and prevention of complications . As a relatively novel technique, the external oblique intercostal block (EOIB) provides analgesia for anterolateral upper abdominal surgery by blocking both the lateral and anterior cutaneous branches of the intercostal nerves between T6-7 and T10-11 . The subcostal transversus abdominis plane (s-TAP) block provides sensory blockade over nearly the entire anterior abdominal wall between T6 and T9. Therefore, it can be considered as part of multimodal analgesia for both laparotomy and laparoscopic abdominal surgical procedures.

The primary aim of this study was to investigate the effects of the external oblique intercostal block (EOIB) and the subcostal transversus abdominis plane (s-TAP) block on postoperative pain scores and opioid consumption in patients undergoing laparoscopic sleeve gastrectomy.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged between 18 and 65 years
  • Patients classified as American Society of Anesthesiologists (ASA) physical status I-III

Exclusion criteria

  • Patients younger than 18 years or older than 65 years
  • Inability to cooperate or comply with study procedures
  • Liver and kidney failure
  • American Society of Anesthesiologists (ASA) IV-V patient
  • External oblique intercostal block(EOİB) and the Subcostal Transversus Abdominis Plane block(s-TAB) are contraindicated

Treatment and study plan

Ultrasound-guided external oblique intercostal plane block

Procedure

Ultrasound-guided external oblique intercostal plane block will be performed at the T6 level using 20 ml of 0.25% bupivacaine at the Immediately after intubation

local anesthetic infiltration

Procedure

Port-site local anesthetic infiltration will be performed with bupivacain after intubation by surgeon.

Subcostal Transversus Abdominis Plane Block (s-TAP)

Procedure

Ultrasound-guided OSTAP block will be performed using 20 ml of 0.25% bupivacaine immediately after intubation.

Primary outcomes

  1. Postoperative Acute Pain Scores

    Time frame: postoperative T1: 0. hours, T2:4.hours,T3:12.hours,T4: 24.hours

    Postoperative acute pain scores assingment with Visual Analog Scores

Secondary outcomes

  1. Total Opioid Consumption

    Time frame: POSTOPERATİVE T1:0 HOURS T2:4. HOURS T3:12.HOURS T4:24.HOURS

    We plan to investigate the effects of the external oblique intercostal block and the subcostal transversus abdominis plane block onopioid consumption in patients undergoing laparoscopic sleeve gastrectomy after surgery.

  2. PATIENT SATISFACTION (Likert Scale) Not satisfied at all 1 Slightly satisfied 2 Moderately satisfied3 Satisfied4 Excellent5 SURGEON SATISFACTION (Likert Scale) Not satisfied at all 1 Slightly satisfied 2 Moderately satisfied3 Satisfied4 Excellent5

    Time frame: Postoperative 24.hours

    Secondary outcomes will include patient- and surgeon-based Likert scale assessments.

  3. Postoperative Nause and Vomiting

    Time frame: Postoperative first 24.hours

Study contacts

Contact information is provided by the study sponsor or research team.

MELİKE BOSTANCI ERKMEN, MD

CONTACT

[email protected]

+905355708530

Tolga Karaçay, MD

CONTACT

[email protected]

+905458718351

Sponsors and collaborators

Lead sponsor

Sanliurfa Education and Research Hospital

Other Gov

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 23, 2026
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.